More about High-Yield Cash Accounts with M1
Brokerage Accounts
Retirement Accounts
Other Accounts
Quotes are delayed by 15 minutes.
1D
1W
1M
3M
6M
YTD
1Y
2Y
5Y
ALL
Market cap
$20.71B
EPS
-1.84
P/E ratio
--
Price to sales
--
Dividend yield
1.618%
Beta
1.091647
Previous close
$47.10
Today's open
$48.33
Day's range
$47.39 - $49.56
52 week range
$33.34 - $85
CEO
Lori D. Koch
Employees
24000
Headquarters
Wilmington, DE
Exchange
New York Stock Exchange
Shares outstanding
418975324
Issue type
Common Stock
Materials
Chemicals
DuPont Defies Headwinds: Big Sale, Bigger Earnings, Soaring Stock
DuPont de Nemours (NYSE: DD) released its fourth-quarter 2025 earnings on February 10, 2026, revealing a complex financial picture as the company navigates its latest structural transformation.
24/7 Wall Street • a day ago

DuPont de Nemours Posts Flat Sales Amid Weak Construction Market
DuPont de Nemours recorded flat fourth-quarter sales as its building technologies business was hurt by weak construction activity.
WSJ • Feb 10, 2026

DuPont Earnings Beat Estimates. Why Things Are Getting Better.
The company reported fourth-quarter earnings per share of 46 cents. Wall Street was looking for 43 cents.
Barrons • Feb 10, 2026

DuPont de Nemours, Inc. (DD) Q4 2025 Earnings Call Transcript
DuPont de Nemours, Inc. (DD) Q4 2025 Earnings Call Transcript
Seeking Alpha • 19 hours ago

DuPont Reports Fourth Quarter and Full Year 2025 Results
Exceeds Fourth Quarter and Full Year 2025 Guidance Initiates First Quarter and Full Year 2026 Guidance Fourth Quarter 2025 Highlights Net Sales of $1.7 billion were flat; organic sales decreased 1% versus year-ago period including a $30 million, or 2%, headwind from the third quarter timing shift GAAP Loss from continuing operations of $(108) million; operating EBITDA of $409 million GAAP EPS from continuing operations of $(0.27); adjusted EPS of $0.46 Cash provided by operating activities from continuing operations of $87 million, including $228 million of separation-related transaction cost and other payments; transaction-adjusted free cash flow of $228 million Full Year 2025 Highlights Net Sales of $6.8 billion increased 2%; organic sales increased 2% versus year-ago period GAAP Income from continuing operations of $98 million; operating EBITDA of $1.63 billion GAAP EPS from continuing operations of $0.21; adjusted EPS of $1.68 Cash provided by operating activities from continuing operations of $560 million, including $462 million of separation-related transaction cost and other payments; transaction-adjusted free cash flow of $689 million WILMINGTON, Del., Feb. 10, 2026 /PRNewswire/ -- DuPont (NYSE: DD) announced its financial results(1) for the fourth quarter and full year ended December 31, 2025 and initiated financial guidance for the first quarter and full year 2026.
PRNewsWire • Feb 10, 2026

DuPont Tops Earnings Estimates in Q4, Reports Flat Y/Y Sales
DD beats Q4 earnings and sales estimates on growth in Healthcare & Water, issued 2026 guidance and narrowed losses.
Zacks Investment Research • 19 hours ago

DuPont Q4: Leaner Operations Are Positive, But Growth Is Unimpressive
DuPont de Nemours, Inc. delivered Q4 results and 2026 guidance modestly ahead of consensus, but near-term growth and demand remain unexciting. DD's transformation into a leaner company post-divestitures may help eliminate its conglomerate discount if execution is strong. Management guides for 3%-5% organic growth in Healthcare & Water Technologies, stabilization in Diversified Industrials, and 60-80 bps margin expansion in 2026.
Seeking Alpha • 14 hours ago

DD Adds FilmTec MXP RO-8038-FF Element to its Dairy Portfolio
DuPont launches FilmTec MXP RO-8038-FF for dairy processors, delivering up to 50% higher productivity and seamless changeover in mesh-wrapped systems.
Zacks Investment Research • Feb 9, 2026

Unveiling DuPont de Nemours (DD) Q4 Outlook: Wall Street Estimates for Key Metrics
Looking beyond Wall Street's top-and-bottom-line estimate forecasts for DuPont de Nemours (DD), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended December 2025.
Zacks Investment Research • Feb 5, 2026

DuPont Launches Medical Grade Liquid Silicone Rubber Series
DD launches Liveo C6-8XX medical-grade liquid silicone rubber, offering lower viscosity, faster molding and USP Class VI compliance for advanced devices.
Zacks Investment Research • Feb 5, 2026

¹ Disclosures

Open an M1 investment account to buy and sell DuPont de Nemours Inc. commission-free¹. Build wealth for the long term using automated trading and transfers.